-
Mashup Score: 0Convalescent Plasma Falls Flat in New Study - 4 year(s) ago
Important finding shows convalescent plasma provides no significant benefit in severe COVID-19 cases.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 2Convalescent Plasma Falls Flat in New Study - 4 year(s) ago
Important finding shows convalescent plasma provides no significant benefit in severe COVID-19 cases.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet-
“In our trial, the use of #convalescent #plasma therapy in addition to standard treatment in patients with severe pneumonia due to #COVID19 did not reduce mortality or improve other clinical outcomes...as compared with placebo.” https://t.co/fsmziplHxJ
-
-
Mashup Score: 0Three patients with X-linked agammaglobulinemia hospitalized for COVID-19 improved with convalescent plasma - 4 year(s) ago
The coronavirus disease 2019 (COVID-19) pandemic has presented a global challenge. The pathogenesis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is complex, and effective therapy is currently lacking. Convalescent plasma transfusion is safe and under investigation for effectiveness.1-6
Categories: Allergy-Immunology, Latest HeadlinesTweet-
In Current Issue (Free)! Three patients with #X- #linked #agammaglobulinemia hospitalized for #COVID- #19 improved with #convalescent #plasma https://t.co/SFghiUrpHF https://t.co/Z0oQNSQ3U2
-
-
Mashup Score: 0Rapid recovery of a SARS-CoV-2–infected X-linked agammaglobulinemia patient after infusion of COVID-19 convalescent plasma - 4 year(s) ago
The high infectivity of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the lack of preexisting immunity among the population, and the complexity of the coronavirus disease 2019 (COVID-19) clinical presentation are some of the underlying reasons of the ongoing worldwide health crisis. Antibodies play relevant roles in antiviral responses,1 and hence, patients with compromised…
Categories: Allergy-Immunology, Latest HeadlinesTweet-
In Current Issue (Free)! Rapid recovery of a #SARS- #CoV- #2–infected #X- #linked #agammaglobulinemia patient after infusion of #COVID- #19 #convalescent #plasma https://t.co/tV9ZZljJ7G https://t.co/v4dwJGrR5G
-
-
Mashup Score: 1Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine | NEJM - 4 year(s) ago
Original Article from The New England Journal of Medicine — Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine
Source: New England Journal of MedicineCategories: Hem/Oncs, Latest HeadlinesTweet-
Phase 1/2 trial ➡️A recombinant #SARSCoV2 spike protein NANOPARTICLE #VACCINE on days 0 & 21 was found to be immunogenic at 5 & 25 μg doses. BOTH doses were equally immunogenic + elicited antibody titers higher than those in #convalescent serum @NEJM . https://t.co/mfxip9VvOm
-
-
Mashup Score: 10NIH Panel Counters FDA: No Solid Data on Plasma for COVID-19 - 4 year(s) ago
The statement from the NIH’s COVID-19 Treatment Guidelines Panel comes a week after the FDA issued an emergency use authorization for treating patients hospitalized with COVID-19.
Source: MedscapeCategories: General Medicine News, Latest HeadlinesTweet-
“#Convalescent plasma should not be considered standard of care for the treatment of patients with #COVID_19,” asserts @NIH. https://t.co/No97Ojo25t
-
-
Mashup Score: 2NIH Panel Counters FDA: No Solid Data on Plasma for COVID-19 - 4 year(s) ago
The statement from the NIH’s COVID-19 Treatment Guidelines Panel comes a week after the FDA issued an emergency use authorization for treating patients hospitalized with COVID-19.
Source: MedscapeCategories: Latest Headlines, SurgeryTweet-
“#Convalescent plasma should not be considered standard of care for the treatment of patients with #COVID19.” https://t.co/EKZ7uMJyIf
-
-
Mashup Score: 0NIH Panel Counters FDA: No Solid Data on Plasma for COVID-19 - 4 year(s) ago
The statement from the NIH’s COVID-19 Treatment Guidelines Panel comes a week after the FDA issued an emergency use authorization for treating patients hospitalized with COVID-19.
Source: MedscapeCategories: General Medicine News, Latest HeadlinesTweet-
“#Convalescent plasma should not be considered standard of care for the treatment of patients with #COVID_19,” asserts @NIH. https://t.co/aA6H0Xo1lp
-
-
Mashup Score: 7
The National Institutes of Health issued the statement shortly after the FDA authorized use of blood plasma for hospitalized patients.
Source: NBC NewsCategories: Healthcare Professionals, Latest HeadlinesTweet-
The saga continues: @Nih says #convalescent plasma not recommended to treat #COVID19 https://t.co/KaFrehOzeb @AmerMedicalAssn @BloodCenterWI @CDCgov @AABB
-
-
Mashup Score: 0Hundreds of San Diegans with COVID-19 have been treated with plasma. But does it work? - 4 year(s) ago
Some anecdotes have been encouraging, but plasma is clearly no panacea
Source: San Diego Union-TribuneCategories: General Medicine News, Latest HeadlinesTweet-
“Whether it’s going to work or not? I think we just don’t know.” Prof. Dennis Burton considers the current evidence surrounding the use of #convalescent #plasma to fight #COVID19 https://t.co/yyuKf0agGd @JonathanWosen @sdut
-
A new #study, published in The New England Journal of Medicine, found that there was no observed significant difference in the clinical status or overall mortality in patients administered a #convalescent plasma transfusion #COVID19 https://t.co/fsmziplHxJ